Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Restructuring Costs (2024 - 2025)

Palisade Bio (PALI) has disclosed Restructuring Costs for 2 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Restructuring Costs rose 22.4% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.4 million, a N/A change, with the full-year FY2024 number at $5.5 million, down 9.74% from a year prior.
  • Restructuring Costs was $1.5 million for Q3 2025 at Palisade Bio, up from $1.1 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.5 million in Q3 2025 to a low of $1.1 million in Q2 2025.